BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14657442)

  • 1. Chemotherapy for bladder cancer.
    Muñoz A; Barceló JR; López-Vivanco G
    N Engl J Med; 2003 Dec; 349(23):2272-3; author reply 2272-3. PubMed ID: 14657442
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.
    Sternberg CN; Parmar MK
    J Clin Oncol; 2001 Sep; 19(18 Suppl):21S-26S. PubMed ID: 11560967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postoperative adjuvant M-VAC chemotherapy for invasive bladder cancer].
    Yamashita S; Taniguchi K; Morimitsu H; Suzu H; Kanetake H; Saito Y; Yushita Y; Sakuragi T
    Hinyokika Kiyo; 1992 May; 38(5):519-24. PubMed ID: 1609658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Birtle AJ; Huddart RA
    BJU Int; 2006 Jun; 97(6):1348; author reply 1348-50. PubMed ID: 16686740
    [No Abstract]   [Full Text] [Related]  

  • 5. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
    Bajorin DF
    J Clin Oncol; 2001 Sep; 19(18 Suppl):17S-20S. PubMed ID: 11560966
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.
    Chechile G; Montie J; Pontes JE; Bukowski RM
    Prog Clin Biol Res; 1990; 353():153-61. PubMed ID: 2217413
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
    BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M; Kotake T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?
    Hall RR
    Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
    Walther PJ
    Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 16. Bladder-sparing approach in the treatment of invasive bladder cancer.
    Wajsman Z; Marino R; Parsons J; Oblon D; McCarley D
    Semin Urol; 1990 Aug; 8(3):210-5. PubMed ID: 2119051
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
    Heidenreich A
    Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
    [No Abstract]   [Full Text] [Related]  

  • 19. Transurethral resection in regionally advanced bladder cancer.
    Herr HW
    Urol Clin North Am; 1992 Nov; 19(4):695-700. PubMed ID: 1441026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.